V. Kaul and P. B. Rai, “The Effect of Risperidone and Olanzapine on blood glucose levels and lipid profile among individuals with schizophrenia”, J. Kathmandu Med. Coll., vol. 11, no. 2, pp. 115–9, Jul. 2022.